Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO can be a frustrating condition for both patients and medical professionals, as it can take a long time to diagnose and treat. In this article, we will explore the medical abbreviation FUO and discuss the various causes, diagnosis, and treatment of this condition.
FUO is a medical abbreviation for fever of unknown origin. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO is defined as a fever that has persisted for more than three weeks without an identifiable cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The condition is most common in elderly patients, but can occur in any age group. It is important to note that FUO is not a specific disease, but rather a diagnosis of exclusion. This means that the cause of the fever must be determined before a diagnosis of FUO can be made.
The exact cause of FUO is often unknown, but there are many potential causes. These include infections, autoimmune disorders, malignancies, and medications. Infections are the most common cause of FUO, with viral infections such as influenza, mononucleosis, and HIV being the most common. Bacterial infections, such as tuberculosis, can also cause FUO. Autoimmune disorders, such as lupus, can also cause FUO. Malignancies, such as lymphoma and leukemia, can also cause FUO. Finally, medications, such as certain antibiotics, can also cause FUO.
The diagnosis of FUO is often a long and frustrating process. It involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The first step in diagnosing FUO is to rule out other causes of fever. This includes testing for infections, autoimmune disorders, malignancies, and medications. If these tests are negative, a diagnosis of FUO can be made. The next step in diagnosing FUO is to identify any underlying cause. This may involve further testing, such as additional laboratory tests, imaging studies, or biopsies. Once the underlying cause is identified, treatment can be tailored to the specific condition.
The treatment of FUO depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed. If an autoimmune disorder is the cause, immunosuppressive medications may be prescribed. If a malignancy is the cause, chemotherapy may be prescribed. If a medication is the cause, the medication may be discontinued.
Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The exact cause of FUO is often unknown, but there are many potential causes. The diagnosis of FUO involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The treatment of FUO depends on the underlying cause. FUO can be a frustrating condition for both patients and medical professionals, but with proper diagnosis and treatment, it can be managed effectively.
1.
Cancer care crowdfunding increasingly common, but rarely successful
2.
First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.
3.
Researchers discover that children who survive cancer have socioeconomic challenges.
4.
Could CT scans be fueling a future rise in cancer cases, as a new study suggests?
5.
SBRT May Beat Brachytherapy in Prostate Cancer
1.
Exploring the Normal Range of Monocytes: A Comprehensive Guide
2.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
3.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
4.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
5.
The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation